Those aiming for above-average market returns often engage in the meticulous process of stock picking. Choosing the right stocks can make a substantial difference in your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
As of close of business last night, Applied Therapeutics Inc’s stock clocked out at $10.24, up 1.49% from its previous closing price of $10.09. In other words, the price has increased by $1.49 from its previous closing price. On the day, 2.18 million shares were traded. APLT stock price reached its highest trading level at $10.6237 during the session, while it also had its lowest trading level at $9.85.
Ratios:
To gain a deeper understanding of APLT’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 1.06 and its Current Ratio is at 1.06. In the meantime, Its Debt-to-Equity ratio is 0.33 whereas as Long-Term Debt/Eq ratio is at 0.29.
On March 26, 2024, RBC Capital Mkts started tracking the stock assigning a Outperform rating and target price of $12.
On February 22, 2024, Leerink Partners started tracking the stock assigning a Outperform rating and target price of $12.Leerink Partners initiated its Outperform rating on February 22, 2024, with a $12 target price.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Aug 22 ’24 when Funtleyder Leslie D. sold 13,530 shares for $5.83 per share. The transaction valued at 78,880 led to the insider holds 277,911 shares of the business.
Perfetti Riccardo sold 22,681 shares of APLT for $132,230 on Aug 22 ’24. The Chief Medical Officer now owns 986,853 shares after completing the transaction at $5.83 per share. On Aug 13 ’24, another insider, Shendelman Shoshana, who serves as the President and CEO of the company, sold 357,423 shares for $6.18 each. As a result, the insider received 2,208,874 and left with 4,810,430 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, APLT now has a Market Capitalization of 1191485440 and an Enterprise Value of 1077140864. For the stock, the TTM Price-to-Sale (P/S) ratio is 115.79 while its Price-to-Book (P/B) ratio in mrq is 202.21. Its current Enterprise Value per Revenue stands at -5080.853 whereas that against EBITDA is -11.672.
Stock Price History:
Over the past 52 weeks, APLT has reached a high of $10.09, while it has fallen to a 52-week low of $1.79. The 50-Day Moving Average of the stock is 29.33%, while the 200-Day Moving Average is calculated to be 75.90%.
Shares Statistics:
It appears that APLT traded 2.58M shares on average per day over the past three months and 1715440 shares per day over the past ten days. A total of 116.36M shares are outstanding, with a floating share count of 87.13M. Insiders hold about 25.12% of the company’s shares, while institutions hold 80.02% stake in the company. Shares short for APLT as of 1728950400 were 14525448 with a Short Ratio of 5.63, compared to 1726185600 on 10815433. Therefore, it implies a Short% of Shares Outstanding of 14525448 and a Short% of Float of 14.140001.
